Navigation Links
Mayo Clinic Study Shows Drug Could Effectively Treat, Prevent the Spread of Breast Cancer
Date:11/1/2007

rom soft tissue to the bone," says Merry Jo Oursler, Ph.D., a Mayo Clinic cell biologist in endocrine research and the senior author of the study.

The researchers caution that although the study's findings are promising, they need to be replicated and tested in clinical trials.

"Our data support the conclusion that 2ME2 could be an important new therapy in the arsenal to fight metastatic breast cancer," the researchers write.

The study is funded by a grant from the National Institutes of Health and the Mayo Clinic.

The study's authors also include: Urszula Iwaniec, Ph.D., and Russell Turner, Ph.D., of Oregon State University; Michael Goblirsch and Denis Clohisy, of the University of University of Minnesota Cancer Center; and Anne Vrabel and Ming Ruan, of Mayo Clinic.

To obtain the latest news releases from Mayo Clinic, go to http://www.mayoclinic.org/news. MayoClinic.com (http://www.mayoclinic.com) is available as a resource for your health stories. For more on Mayo Clinic research, go to http://www.mayo.edu.


'/>"/>
SOURCE Mayo Clinic
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
9. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...PHILADELPHIA,Nov.25/PRNewswire-FirstCall/--ERT(Nas...,theCompany,sPresidentandCEO,andKeithSchneck,theCo...presentatthe21stAnnualPiperJaffrayHealthCareConfer...rk. ,, Interestedpartiesmayaccessthepresentatio...ww.ert.com .Thewebcastmayalsobeaccessedat http://w...
(Date:11/25/2009)...EXTON,Pa.,Nov.25/PRNewswire/--BioTrendsResearchGro...elara report,thefirstinamulti-phasesyndicatedmark...Biotech,sStelara,fromproductlaunchthroughthefirsts...quantitativeinformationfrom75uniqueDermatologistsa...assesstrialanduseofStelara,obstaclestouse,typicalp...
(Date:11/25/2009)...WESTPALMBEACH,Fla.,Nov.25/PRNewswire-FirstCall/--F...ciallythe27millionlivingwithuntreated hearingloss ...ndyBeyer. ,, Dr.Beyer,seniorvicepresidentofHear...d hearingaids companies,saidstudieshavelinkedheari...chcaneasilybeintensifiedatholidaygatheringswithfam...
Breaking Medicine Technology:ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2Oncothyreon reports third quarter 2009 financial results 26amp 3B provides product pipeline update 14800 1Oncothyreon reports third quarter 2009 financial results 26amp 3B provides product pipeline update 14800 2Oncothyreon reports third quarter 2009 financial results 26amp 3B provides product pipeline update 14800 3Oncothyreon reports third quarter 2009 financial results 26amp 3B provides product pipeline update 14800 4Oncothyreon reports third quarter 2009 financial results 26amp 3B provides product pipeline update 14800 5Oncothyreon reports third quarter 2009 financial results 26amp 3B provides product pipeline update 14800 6Oncothyreon reports third quarter 2009 financial results 26amp 3B provides product pipeline update 14800 7Oncothyreon reports third quarter 2009 financial results 26amp 3B provides product pipeline update 14800 8MedCath Corporation Reports Fourth Quarter Earnings 6187 1MedCath Corporation Reports Fourth Quarter Earnings 6187 2MedCath Corporation Reports Fourth Quarter Earnings 6187 3MedCath Corporation Reports Fourth Quarter Earnings 6187 4MedCath Corporation Reports Fourth Quarter Earnings 6187 5MedCath Corporation Reports Fourth Quarter Earnings 6187 6MedCath Corporation Reports Fourth Quarter Earnings 6187 7MedCath Corporation Reports Fourth Quarter Earnings 6187 8MedCath Corporation Reports Fourth Quarter Earnings 6187 9MedCath Corporation Reports Fourth Quarter Earnings 6187 10MedCath Corporation Reports Fourth Quarter Earnings 6187 11MedCath Corporation Reports Fourth Quarter Earnings 6187 12MedCath Corporation Reports Fourth Quarter Earnings 6187 13MedCath Corporation Reports Fourth Quarter Earnings 6187 14MedCath Corporation Reports Fourth Quarter Earnings 6187 15MedCath Corporation Reports Fourth Quarter Earnings 6187 16MedCath Corporation Reports Fourth Quarter Earnings 6187 17MedCath Corporation Reports Fourth Quarter Earnings 6187 18MedCath Corporation Reports Fourth Quarter Earnings 6187 19Endo Pharmaceuticals and LecTec Settle Patent Dispute 6182 1Endo Pharmaceuticals and LecTec Settle Patent Dispute 6182 2Endo Pharmaceuticals and LecTec Settle Patent Dispute 6182 3Endo Pharmaceuticals and LecTec Settle Patent Dispute 6182 4
(Date:11/25/2009)... Nationwide Imaging Services, known as one of th...nostic imaging equipment, now offering a total sol...g options, service and installation with acquisiti...nologies of California) , ... Imaging Services is proud to announce its acquisi...
(Date:11/25/2009)... BioSpace.com, the premier resource for life sci...dition of the BioForest™ Hotbed Campaign thi...O (Vocus) November 25, 2009 -- BioSpace.com, the p...mation, unveiled the third edition of the BioFores...is regional campaign is a promotional effort highl...
(Date:11/25/2009)...ertoShareRecordsSafely,ImproveCare ,, WASHING...VeteransAffairs(VA)andKaiserPermanentetodayannounc...stoourNation,sheroes.VAandKaiserPermanentearelaunc...EHR)informationusingtheNationwideHealthInformation...nServices. ,, "Theabilitytosharecriticalhealthi...
(Date:11/25/2009)...v.25/PRNewswire/--dazzlesmile,llc www.dazzlesmile....cience.com havefileda67-pagefederallawsuitagainstE...seWillms,FarendServicesLimited,andAtLastFulfillmen...trictCourtfortheDistrictofUtah,allegesmassivenatio...andedteethwhiteningproducts,violationsoftheRackete...
(Date:11/25/2009)...ov.25/PRNewswire/--DanielTouizer,CEOof Ci n e ...healthinsurancebenefitprograms,isconcernedthatthel...lyoneinfiveAmericansarewithoutafull-timejobandunli...ratesaredeterminedbytheU-6number,whichhasspikedto1... T ouizer ."Thesestatisticsarealarmingasitmeans...
Breaking Medicine News(10 mins):Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 3Health News:BioSpace Showcases Leading Life-Science Companies in the Northwest 2Health News:VA and Kaiser Permanente Invite Veterans to Participate in Health Record Pilot Program 2Health News:dazzlesmile Sues Epic Advertising and Jesse Willms 2Health News:Cinergy Health Commentary on Health Care for the Unemployed 2
...untain of Life is excited to announce that the Dav...ip product, VaNu. , , "Golfers drinking VaNu r... focus, better health, and an improved sense of we...ately became interested in the beverage after lear...
...los Endoscopy, Inc. (Pink Sheets: SNDY) is pleased...roduct line, the MammoView(TM), was featured in t...agazine in the December 2008 issue. The article fo...w(TM) product line employs advanced microendoscope...
...loped for assay kits from Beacon Analytical System...oplate readers with SoftMax(R), Pro analytical ...FirstCall/ - MDS Analytical Technologies, a leader...nalytical Systems, which focuses on the developmen...
... 19 The Providence Service Corporation (Nasdaq: ... has been awarded a $1.5 million annual contract t...ess center in Orange County, California. The cont...ed delivery model is very much aligned with Orange...
...f., Feb. 19 Based on its recent analysis of the N...p; Sullivan recognizes Horphag Research Ltd. with ...lence in Research of the Year Award. The award ack...ingredient, Pycnogenol(R), across industries such ...
...., Feb. 19 Smith & Nephew,s Advanced Wound Ma...d that the United States Patent and Trademark Offi...ree of KCI,s negative pressure wound therapy (NPWT...re-examined claims are not patentable, including t...
Other Medicine News:Health News:World-Renowned Golf Instructor David Leadbetter Promotes VaNu 2Health News:Solos Endoscopy, Inc.'s MammoView(TM) Featured in December Issue of Surgical Products Magazine 2Health News:MDS Analytical Technologies Announces Validation of Two More Kits for High-Throughput Detection of Melamine in Food 2Health News:MDS Analytical Technologies Announces Validation of Two More Kits for High-Throughput Detection of Melamine in Food 3Health News:MDS Analytical Technologies Announces Validation of Two More Kits for High-Throughput Detection of Melamine in Food 4Health News:Providence Service Corporation California Subsidiary Awarded $1.5 Million Contract Under State's Mental Health Services Act 2Health News:Frost & Sullivan Recognizes Horphag's Pioneering R&D Efforts in Health Ingredients 2Health News:Frost & Sullivan Recognizes Horphag's Pioneering R&D Efforts in Health Ingredients 3Health News:Frost & Sullivan Recognizes Horphag's Pioneering R&D Efforts in Health Ingredients 4Health News:United States Patent Office Rejects KCI's Patents 2Health News:United States Patent Office Rejects KCI's Patents 3
Neuropack MEB-7102 Evoked Potential Measuring System
Neuropack MEB-2200 Evoked Potential/EMG Measuring System
Myoquick 1200/1400/1800
Sierra Wave
Medicine Products: